IndraLab

Statements


| 1

reach
"According to the obtained data, many USP51-overexpressing tumors are immune exclusion tumors and, in particular, ACTA2 overexpression creates a restrictive barrier to protect tumors from killing by CD[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"